Cancel
John Strafford
VP Business Development
@
Isomorphic Labs
dwfz@y5vkge7vtgy7t5.0ud
Sign up to see email
Known information
- Holds a PhD in Biochemical Engineering from UCL
- Earned an MRes in Bioinformatics from the University of York
- Previously served as Senior Vice President and Head of Business Development, Alliance Management and New Product Development at Silence Therapeutics
- Worked as a Senior Business Development Manager at Advanz Pharma
- Has experience in unlocking commercial possibilities at Novasecta, Navigant, and Antisoma
- Led negotiations and successfully launched multiple partnerships, including deals shortlisted for Scrip Awards' Best Partnership Alliance 2020 and finalist for LSX Leaders Lifestars Awards Deal of the Year 2019
- Published in the Journal of Biotechnology, Organic & Biomolecular Chemistry, and Informa - In Vivo
About Isomorphic Labs
Isomorphic Labs, founded in 2021, is an Alphabet subsidiary leveraging AI and computational methods, including their development of AlphaFold 3, to revolutionize drug discovery.
Report inaccurate information
